Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, mono...

por Dazzi, H., Hasleton, P. S., Thatcher, N., Wilkes, S., Swindell, R., Chatterjee, A. K.
Publicado 1990

Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and s...

por Dazzi, H., Hasleton, P. S., Thatcher, N., Barnes, D. M., Wilkes, S., Swindell, R., Lawson, R. A.
Publicado 1989

Recombinant interleukin-2 (rIL-2) given intrasplenically and intravenously for advanced malignant melanoma. A phase I and II study.

por Thatcher, N., Dazzi, H., Johnson, R. J., Russell, S., Ghosh, A. K., Moore, M., Chadwick, G., Craig, R. D.
Publicado 1989

Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: a phase II study.

por Thatcher, N., Dazzi, H., Mellor, M., Ghosh, A., Carrington, B., Johnson, R. J., Loriaux, E. M., Craig, R. P.
Publicado 1990